These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 9437331)

  • 1. Interferon treatment for corneolimbal squamous dysplasia.
    Hu FR; Wu MJ; Kuo SH
    Am J Ophthalmol; 1998 Jan; 125(1):118-9. PubMed ID: 9437331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical versus medical treatment of ocular surface squamous neoplasia: a comparison of recurrences and complications.
    Nanji AA; Moon CS; Galor A; Sein J; Oellers P; Karp CL
    Ophthalmology; 2014 May; 121(5):994-1000. PubMed ID: 24411578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathological characteristics of ocular surface squamous neoplasia in an Asian population.
    Kim BH; Kim MK; Wee WR; Oh JY
    Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2569-73. PubMed ID: 24006080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of conjunctival and corneal epithelial neoplasia with retinoic acid and topical interferon alfa-2b: long-term follow-up.
    Krilis M; Tsang H; Coroneo M
    Ophthalmology; 2012 Oct; 119(10):1969-73. PubMed ID: 22704834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia.
    Vann RR; Karp CL
    Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical interferon alfa-2b for management of ocular surface squamous neoplasia in 23 cases: outcomes based on American Joint Committee on Cancer classification.
    Shah SU; Kaliki S; Kim HJ; Lally SE; Shields JA; Shields CL
    Arch Ophthalmol; 2012 Feb; 130(2):159-64. PubMed ID: 22332208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regression of limbal epithelial dysplasia with topical interferon.
    Maskin SL
    Arch Ophthalmol; 1994 Sep; 112(9):1145-6. PubMed ID: 8085957
    [No Abstract]   [Full Text] [Related]  

  • 8. Rapid response of refractory ocular surface dysplasia to combination treatment with topical all-trans retinoic acid and interferon alfa-2b.
    Skippen B; Tsang HH; Assaad NN; Coroneo MT
    Arch Ophthalmol; 2010 Oct; 128(10):1368-9. PubMed ID: 20938011
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of conjunctival and corneal intraepithelial neoplasia with topical interferon alpha-2b.
    Karp CL; Moore JK; Rosa RH
    Ophthalmology; 2001 Jun; 108(6):1093-8. PubMed ID: 11382635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of recurrent corneal and conjunctival intraepithelial neoplasia with topical interferon alfa 2b.
    Boehm MD; Huang AJ
    Ophthalmology; 2004 Sep; 111(9):1755-61. PubMed ID: 15350333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon Alfa-2b for Pigmented Ocular Surface Squamous Neoplasia: A Report of 8 Lesions.
    Kaliki S; Sharma A; Vempuluru VS
    Cornea; 2021 Feb; 40(2):142-146. PubMed ID: 32355112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined intraepithelial squamous neoplasia and atypical fibroxanthoma of the cornea and limbus.
    Engelbrecht NE; Ford JG; White WL; Yeatts RP
    Am J Ophthalmol; 2000 Jan; 129(1):94-6. PubMed ID: 10653421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giant ocular surface squamous neoplasia managed with interferon alpha-2b as immunotherapy or immunoreduction.
    Kim HJ; Shields CL; Shah SU; Kaliki S; Lally SE
    Ophthalmology; 2012 May; 119(5):938-44. PubMed ID: 22361315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b.
    Schechter BA; Koreishi AF; Karp CL; Feuer W
    Ophthalmology; 2008 Aug; 115(8):1291-6, 1296.e1. PubMed ID: 18187195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ocular surface squamous neoplasia.
    Pe'er J
    Ophthalmol Clin North Am; 2005 Mar; 18(1):1-13, vii. PubMed ID: 15763187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Squamous carcinoma and dysplasia of the conjunctiva and cornea: an analysis of 101 cases.
    Yousef YA; Finger PT
    Ophthalmology; 2012 Feb; 119(2):233-40. PubMed ID: 22189448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful management of conjunctival intraepithelial neoplasia by interferon alpha-2b.
    Kobayashi A; Yoshita T; Uchiyama K; Shirao Y; Kitagawa K; Fujisawa A; Tseng SC
    Jpn J Ophthalmol; 2002; 46(2):215-7. PubMed ID: 12062230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia.
    Holcombe DJ; Lee GA
    Am J Ophthalmol; 2006 Oct; 142(4):568-71. PubMed ID: 17011846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relapsed ocular squamous surface neoplasia treated with topical interferon alfa-2b.
    Rocha-de-Lossada C; Alba-Linero C; Borroni D; Rachwani-Anil R; Zamorano-Martín F; Rodríguez-Calvo-de-Mora M
    Rom J Ophthalmol; 2020; 64(1):62-65. PubMed ID: 32292860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Topical interferon alfa-2b or surgical excision for primary treatment of conjunctiva-cornea intraepithelial neoplasia].
    Huerva V
    Arch Soc Esp Oftalmol; 2009 Jan; 84(1):5-6. PubMed ID: 19173133
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.